Barry Callebaut has halted manufacturing operations at its Weize chocolate plant in Belgium as a precautionary measure while conducting its root cause analysis and risk assessment after detecting salmonella in a production lot.
The company identified lecithin as the source of the contamination.
All chocolate products manufactured at the facility since June 25 have been placed on hold.
After the analysis, the lines will be cleaned and sanitized before production can resume.
Barry Callebaut, which informed the Belgian food authorities (FAVV) about the incident, said that their robust food safety programs allowed them to identify lecithin as the source of the contamination quickly.
The company added that they are reaching out to all customers who may have received impacted products.
The news comes after Ferrero temporarily suspended production at its Arlon facility in Belgium after the site was linked to a salmonella outbreak.


Kakaku.com Stock Surges on EQT Takeover Interest Amid Rising Japan Deal Activity
Samsung Boosts DRAM Supply to Tesla as AI-Driven Memory Demand Surges
Novocure Stock Surges 30% After FDA Approves Optune Pax for Pancreatic Cancer Treatment
Judge Dismisses Elon Musk’s Fraud Claims Against OpenAI, Trial to Proceed on Remaining Allegations
RFK Jr. Overhauls Federal Autism Panel, Sparking Medical Community Backlash
Foreign Investors Drive Surge in Japanese Stocks Amid AI Rally and Improved Risk Sentiment
Meta Expands AI Training With Employee Activity Tracking Tools
USDA Plans to Expand Farmer Surveys to Improve Crop Report Accuracy
U.S. Officials Express Optimism Over New CDC Director Selection Amid Vaccine Policy Turmoil
European Car Sales Surge in March as EV and Hybrid Demand Accelerates
Organon Stock Surges After Reports of $13 Billion Buyout Bid by Sun Pharma
Daiichi Sankyo Stock Drops After Earnings Delay and Oncology Review
Gold Prices Edge Higher Amid Middle East Tensions and Ceasefire Uncertainty
Microsoft Commits $18 Billion to Expand AI and Cloud Infrastructure in Australia
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
SpaceX Eyes $60B Cursor Deal to Boost AI Power Ahead of IPO
Why Global Web3 Projects Can't Afford to Skip South Korea: TokenPost Unveils Data-Driven Entry Solutions 



